Prohibiting health maintenance organizations from excluding coverage for certain cancer treatment drugs; prohibiting insurers and health maintenance organizations from excluding coverage for certain drugs on certain grounds; specifying a requirement for the prior authorization form adopted by the Financial Services Commission by rule; specifying requirements for, and restrictions on, health insurers and pharmacy benefits managers relating to prior authorization information, requirements, restrictions, and changes, etc.